• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿外泌体的蛋白质组学分析确定了镰状细胞肾病早期诊断的新型潜在生物标志物:一项基于性别的研究。

Proteomic analyses of urinary exosomes identify novel potential biomarkers for early diagnosis of sickle cell nephropathy, a sex-based study.

作者信息

Packialakshmi Balamurugan, Limerick Emily, Ackerman Hans C, Lin Xionghao, Nekhai Sergei, Oliver James D, Stewart Ian J, Knepper Mark A, Fitzhugh Courtney, Zhou Xiaoming

机构信息

Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD, United States.

Cellular and Molecular Therapeutic Branch, National Heart Lung and Blood Institute, Bethesda, MD, United States.

出版信息

Front Physiol. 2024 Feb 15;15:1300667. doi: 10.3389/fphys.2024.1300667. eCollection 2024.

DOI:10.3389/fphys.2024.1300667
PMID:38426210
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10901968/
Abstract

Sickle cell nephropathy (SCN) is a leading cause of morbidity and mortality in sickle cell disease (SCD). Early intervention is crucial for mitigating its effects. However, current diagnostic methods rely on generic tests and may not detect SCN until irreversible renal damage occurs. Therefore, specific biomarkers for early diagnosis of SCN are needed. Urinary exosomes, membrane-bound vesicles secreted by renal podocytes and epithelial cells, contain both common and cell type-specific membrane and cytosolic proteins, reflecting the physiologic and pathophysiologic states of the kidney. Using proteomics, we analyzed the proteomes of urinary exosomes from humanized SCD mice at 2 months (without albuminuria) and 4 months (with albuminuria) of age. Excretion of 164 proteins were significantly increased and 176 proteins was significantly decreased in the exosomes when mice developed albuminuria. Based on the relevance to SCD, chronic kidney disease and Western blot confirmation in mice, we analyzed protein abundance of heparanase, cathepsin C, α2-macroglobulin and sarcoplasmic endoplasmic Ca ATPase-3 (SERCA3) in the urinary exosomes and urine of 18 SCD subjects without albuminuria and 12 subjects with albuminuria using Western blot analyses. Both male and female subjects increased or tended to increase the excretion of these proteins in their urinary exosomes upon developing albuminuria, but female subjects demonstrated stronger correlations between the excretion of these proteins and urine albumin creatinine ratio (UACR) compared to male subjects. In contrast, exosomal excretion of Tamm-Horsfall protein, β-actin and SHP-1 was independent of albuminuria. These findings provide a foundation for a time-course study to determine whether increases in the levels of these proteins precede the onset of albuminuria in patients, which will help determine the potential of these proteins as biomarkers for early detection of SCN.

摘要

镰状细胞肾病(SCN)是镰状细胞病(SCD)发病和死亡的主要原因。早期干预对于减轻其影响至关重要。然而,目前的诊断方法依赖于通用检测,可能直到发生不可逆的肾损伤才检测到SCN。因此,需要用于SCN早期诊断的特异性生物标志物。尿外泌体是肾足细胞和上皮细胞分泌的膜结合囊泡,包含常见的和细胞类型特异性的膜蛋白和胞质蛋白,反映肾脏的生理和病理生理状态。我们使用蛋白质组学分析了2月龄(无蛋白尿)和4月龄(有蛋白尿)的人源化SCD小鼠尿外泌体的蛋白质组。当小鼠出现蛋白尿时,外泌体中164种蛋白质的排泄量显著增加,176种蛋白质显著减少。基于与SCD、慢性肾病的相关性以及在小鼠中的蛋白质印迹证实,我们使用蛋白质印迹分析了18名无蛋白尿的SCD受试者和12名有蛋白尿的受试者尿外泌体和尿液中乙酰肝素酶、组织蛋白酶C、α2-巨球蛋白和肌浆内质网Ca ATP酶-3(SERCA3)的蛋白质丰度。男性和女性受试者在出现蛋白尿时,其尿外泌体中这些蛋白质的排泄量均增加或有增加趋势,但与男性受试者相比,女性受试者中这些蛋白质的排泄量与尿白蛋白肌酐比值(UACR)之间的相关性更强。相比之下,Tamm-Horsfall蛋白、β-肌动蛋白和SHP-1的外泌体排泄与蛋白尿无关。这些发现为一项时间进程研究奠定了基础,以确定这些蛋白质水平的升高是否先于患者蛋白尿的发作,这将有助于确定这些蛋白质作为SCN早期检测生物标志物的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef32/10901968/f2e48d2a220e/fphys-15-1300667-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef32/10901968/1b46ed84ed66/fphys-15-1300667-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef32/10901968/44ecfb67f7ef/fphys-15-1300667-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef32/10901968/4703fa3a337c/fphys-15-1300667-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef32/10901968/4def7e2dbbc6/fphys-15-1300667-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef32/10901968/1895ff2c6827/fphys-15-1300667-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef32/10901968/af0c54de2e01/fphys-15-1300667-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef32/10901968/66c97de02881/fphys-15-1300667-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef32/10901968/f2e48d2a220e/fphys-15-1300667-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef32/10901968/1b46ed84ed66/fphys-15-1300667-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef32/10901968/44ecfb67f7ef/fphys-15-1300667-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef32/10901968/4703fa3a337c/fphys-15-1300667-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef32/10901968/4def7e2dbbc6/fphys-15-1300667-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef32/10901968/1895ff2c6827/fphys-15-1300667-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef32/10901968/af0c54de2e01/fphys-15-1300667-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef32/10901968/66c97de02881/fphys-15-1300667-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef32/10901968/f2e48d2a220e/fphys-15-1300667-g008.jpg

相似文献

1
Proteomic analyses of urinary exosomes identify novel potential biomarkers for early diagnosis of sickle cell nephropathy, a sex-based study.尿外泌体的蛋白质组学分析确定了镰状细胞肾病早期诊断的新型潜在生物标志物:一项基于性别的研究。
Front Physiol. 2024 Feb 15;15:1300667. doi: 10.3389/fphys.2024.1300667. eCollection 2024.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2017 Jul 3;7(7):CD012380. doi: 10.1002/14651858.CD012380.pub2.
4
Sickle Cell Disease镰状细胞病
5
Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.血管紧张素转换酶(ACE)抑制剂用于镰状细胞病患者的蛋白尿和微量白蛋白尿。
Cochrane Database Syst Rev. 2015 Jun 4;2015(6):CD009191. doi: 10.1002/14651858.CD009191.pub3.
6
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD012380. doi: 10.1002/14651858.CD012380.pub3.
7
Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.血管紧张素转换酶(ACE)抑制剂用于镰状细胞病患者的蛋白尿和微量白蛋白尿。
Cochrane Database Syst Rev. 2013 Mar 28(3):CD009191. doi: 10.1002/14651858.CD009191.pub2.
8
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
9
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
10
Assessment and prediction of diabetic kidney disease in patients with type 2 diabetes mellitus by using an advanced biomarkers.使用先进生物标志物对2型糖尿病患者的糖尿病肾病进行评估和预测。
Nefrologia (Engl Ed). 2025 Jun-Jul;45(6):101330. doi: 10.1016/j.nefroe.2025.101330.

引用本文的文献

1
Role of Traditional Stroke Risk Factors Aiding in Prediction of Infarcts in Adult Patients With Sickle Cell Disease.传统中风危险因素在镰状细胞病成年患者梗死预测中的作用
J Am Heart Assoc. 2024 Jun 18;13(12):e034798. doi: 10.1161/JAHA.124.034798. Epub 2024 Jun 6.

本文引用的文献

1
Sex differences in progression of kidney disease in sickle cell disease.镰状细胞病患者肾脏疾病进展中的性别差异。
Haematologica. 2023 May 1;108(5):1436-1441. doi: 10.3324/haematol.2022.281677.
2
Glomerular filtration rate abnormalities in sickle cell disease.镰状细胞病中的肾小球滤过率异常
Front Med (Lausanne). 2022 Oct 21;9:1029224. doi: 10.3389/fmed.2022.1029224. eCollection 2022.
3
Urinary Exosomal Cystatin C and Lipopolysaccharide Binding Protein as Biomarkers for Antibody-Mediated Rejection after Kidney Transplantation.
尿外泌体胱抑素C和脂多糖结合蛋白作为肾移植后抗体介导排斥反应的生物标志物
Biomedicines. 2022 Sep 21;10(10):2346. doi: 10.3390/biomedicines10102346.
4
Differential expression of aerobic oxidative metabolism-related proteins in diabetic urinary exosomes.糖尿病尿外泌体中与有氧氧化代谢相关蛋白的差异表达。
Front Endocrinol (Lausanne). 2022 Sep 14;13:992827. doi: 10.3389/fendo.2022.992827. eCollection 2022.
5
Soluble urokinase-type plasminogen activator receptor in sickle cell disease-associated chronic kidney disease.镰状细胞病相关慢性肾脏病中的可溶性尿激酶型纤溶酶原激活物受体
Blood Adv. 2023 May 9;7(9):1854-1857. doi: 10.1182/bloodadvances.2022008374.
6
The nephropathy of sickle cell trait and sickle cell disease.镰状细胞性状和镰状细胞病的肾病
Nat Rev Nephrol. 2022 Jun;18(6):361-377. doi: 10.1038/s41581-022-00540-9. Epub 2022 Feb 21.
7
Tourniquet-induced lower limb ischemia/reperfusion reduces mitochondrial function by decreasing mitochondrial biogenesis in acute kidney injury in mice.止血带引起的下肢缺血/再灌注通过减少急性肾损伤小鼠的线粒体生物发生来降低线粒体功能。
Physiol Rep. 2022 Feb;10(3):e15181. doi: 10.14814/phy2.15181.
8
Alpha-2-macroglobulin in hemostasis and thrombosis: An underestimated old double-edged sword.α-2-巨球蛋白在止血和血栓形成中的作用:一把被低估的古老双刃剑。
J Thromb Haemost. 2022 Apr;20(4):806-815. doi: 10.1111/jth.15647. Epub 2022 Jan 30.
9
Sickle cell disease promotes sex-dependent pathological bone loss through enhanced cathepsin proteolytic activity in mice.镰状细胞病通过增强小鼠组织蛋白酶的蛋白水解活性促进性别依赖性病理性骨丢失。
Blood Adv. 2022 Mar 8;6(5):1381-1393. doi: 10.1182/bloodadvances.2021004615.
10
Urinary Kringle Domain-Containing Protein HGFL: A Validated Biomarker of Early Sickle Cell Anemia-Associated Kidney Disease.尿含kringle 域蛋白 HGFL:早期镰状细胞贫血相关肾病的有效生物标志物。
Am J Nephrol. 2021;52(7):582-587. doi: 10.1159/000517056. Epub 2021 Aug 10.